285 Results

People

  1. Kelsen
    Kelsen
  2. Zelefsky
    Zelefsky
  3. Gralla
    Gralla
  4. Kemeny
    Kemeny
  5. Scher
    Scher
  6. Casper
    Casper
  7. Kollmeier
    Kollmeier
  8. Minsky
    Minsky
  9. Heelan
    Heelan
  10. Ilson
    Ilson

Groups

  1. Department of Medicine (144)
  2. Solid Tumor Oncology Division (114)
  3. Survivorship Research (55)
  4. Gastrointestinal Oncology Service (48)
  5. Center for Pancreatic Cancer Research (41)
  6. Surgery (37)
  7. Hematologic Malignancies, Division of (35)
  8. Radiation Oncology, Department of (32)
  9. Center for Hematologic Malignancies (28)
  10. Genitourinary Oncology Service (28)
  1. "gastrointestinal toxicity"
Formats
  1. Journal Article (272)
  2. Review (4)
  3. Editorial (3)
  4. Research Letter (2)
  5. Conference Paper (1)
  6. Correspondence (1)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (144)
  2. Solid Tumor Oncology Division (114)
  3. Survivorship Research (55)
  4. Gastrointestinal Oncology Service (48)
  5. Center for Pancreatic Cancer Research (41)
  6. Surgery (37)

More Groups

People
  1. David Kelsen (26)
  2. Michael Zelefsky (23)
  3. Nancy Kemeny (14)
  4. Howard Scher (12)
  5. Richard Gralla (12)
  6. Bruce Minsky (11)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (3)
  5. 2020 (3)
  6. 2019 (3)

More Years

Publications
  1. Cancer Treatment Reports (27)
  2. Cancer (23)
  3. Journal of Clinical Oncology (21)
  4. International Journal of Radiation Oncology, Biology, Physics (20)
  5. Gynecologic Oncology (9)
  6. Hematology/Oncology Clinics of North America (6)

More Publications

Publishers
  1. Elsevier Inc. (65)
  2. Wiley Blackwell (28)
  3. National Cancer Institute (27)
  4. American Society of Clinical Oncology (21)
  5. Elsevier Science, Inc. (18)
  6. Springer (14)

More Publishers

Results (285)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
    Journal Article

    Hensley, M. L.; Sill, M. W.; Scribner, D. R. Jr; Brown, J.; DeBernardo, R. L.; Hartenbach, E. M.; McCourt, C. K.; Bosscher, J. R.; Gehrig, P. A.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients
    Journal Article

    Harnicar, S.; Adel, N.; Jurcic, J.
    Journal of Oncology Pharmacy Practice (2009)

    Fulltext@MSK | Save
  • The future of small molecule inhibitors in lymphoma
    Journal Article

    Gerecitano, J.
    Current Oncology Reports (2009)

    Fulltext@MSK | Save
  • Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: Analysis of Gynecologic Oncology Group Trials
    Journal Article

    Farley, J. H.; Tian, C.; Rose, G. S.; Brown, C. L.; Birrer, M.; Maxwell, G. L.
    Cancer (2009)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for liver metastases
    Journal Article

    Dawood, O.; Mahadevan, A.; Goodman, K. A.
    European Journal of Cancer (2009)

    Fulltext@MSK | Save
  • Arsenic trioxide in recurrent urothelial cancer: A Cancer and Leukemia Group B phase II trial (CALGB 99903)
    Journal Article

    Bajorin, D. F.; Halabi, S.; Small, E.
    Clinical Genitourinary Cancer (2009)

    Fulltext@MSK | Save
  • Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy
    Journal Article

    Zivanovic, O.; Alektiar, K. M.; Sonoda, Y.; Zhou, Q.; Iasonos, A.; Tew, W. P.; Diaz, J. P.; Chi, D. S.; Barakat, R. R.; Abu-Rustum, N. R.
    Gynecologic Oncology (2008)

    Fulltext@MSK | Save
  • Combined brachytherapy with external beam radiotherapy for localized prostate cancer: Reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy
    Journal Article

    Zelefsky, M. J.; Nedelka, M. A.; Arican, Z. L.; Yamada, Y.; Cohen, G. N.; Shippy, A. M.; Park, J. J.; Zaider, M.
    Brachytherapy (2008)

    Fulltext@MSK | Save
  • Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
    Journal Article

    Rosenberg, J. E.; Halabi, S.; Sanford, B. L.; Himelstein, A. L.; Atkins, J. N.; Hohl, R. J.; Millard, F.; Bajorin, D. F.; Small, E. J.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • The adverse events of chemotherapy for retinoblastoma: What are they? Do we know?
    Journal Article

    Rizzuti, A. E.; Dunkel, I. J.; Abramson, D. H.
    Archives of Ophthalmology (2008)

    Fulltext@MSK | Save